CD274 and non-small cell lung carcinoma: A unique cohort of LA-NSCLC patients enrolled on the FLARE-RT protocol (NCT02773238) and received chemoradiation guided by functional lung avoidance planning and selective dose escalation based on mid-treatment fluorodeoxyglucose-PET response status, with approximately half of patients receiving consolidation anti-PD-L1 ICI-therapy.